Loading...
Viemed Healthcare, Inc.
VMD•NASDAQ
Healthcare
Medical - Devices
$6.12
$-0.17(-2.70%)
Viemed Healthcare, Inc. (VMD) Financial Performance & Income Statement Overview
Review Viemed Healthcare, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
22.54%
↑ 22.54%
Operating Income Growth
24.91%
↑ 24.91%
Net Income Growth
9.98%
↑ 9.98%
Operating Cash Flow Growth
-13.54%
↓ 13.54%
Operating Margin
8.25%
↑ 8.25%
Gross Margin
58.55%
↑ 58.55%
Net Profit Margin
5.28%
↑ 5.28%
ROE
9.63%
↑ 9.63%
ROIC
20.55%
↑ 20.55%
Viemed Healthcare, Inc. (VMD) Income Statement & Financial Overview
Review Viemed Healthcare, Inc.'s (VMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $60.70M | $58.004M | $54.97M | $50.59M |
| Cost of Revenue | $24.56M | $23.63M | $22.45M | $20.79M |
| Gross Profit | $36.14M | $34.37M | $32.52M | $29.80M |
| Gross Profit Ratio | $0.60 | $0.59 | $0.59 | $0.59 |
| R&D Expenses | $803000.00 | $757000.00 | $758000.00 | $750000.00 |
| SG&A Expenses | $29.73M | $28.38M | $27.90M | $26.25M |
| Operating Expenses | $29.69M | $28.74M | $29.22M | $27.39M |
| Total Costs & Expenses | $53.57M | $52.38M | $51.67M | $48.18M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $147000.00 | $225000.00 | $254000.00 | $150000.00 |
| Depreciation & Amortization | $6.37M | $6.41M | $6.31M | $6.29M |
| EBITDA | $12.82M | $12.13M | $10.50M | $8.70M |
| EBITDA Ratio | $0.21 | $0.21 | $0.19 | $0.17 |
| Operating Income | $6.45M | $5.63M | $3.29M | $2.20M |
| Operating Income Ratio | $0.11 | $0.10 | $0.06 | $0.04 |
| Other Income/Expenses (Net) | -$147000.00 | -$129000.00 | -$1.37M | -$83000.00 |
| Income Before Tax | $6.30M | $5.50M | $2.25M | $2.12M |
| Income Before Tax Ratio | $0.10 | $0.09 | $0.04 | $0.04 |
| Income Tax Expense | $1.88M | $1.59M | $768000.00 | $518000.00 |
| Net Income | $4.32M | $3.88M | $1.47M | $1.60M |
| Net Income Ratio | $0.07 | $0.07 | $0.03 | $0.03 |
| EPS | $0.11 | $0.10 | $0.04 | $0.04 |
| Diluted EPS | $0.10 | $0.10 | $0.04 | $0.04 |
| Weighted Avg Shares Outstanding | $39.03M | $38.87M | $38.82M | $38.72M |
| Weighted Avg Shares Outstanding (Diluted) | $41.52M | $40.78M | $40.55M | $40.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan